Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression (Q43698813)
Jump to navigation
Jump to search
scientific article published in August 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression |
scientific article published in August 2001 |
Statements
1 reference
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression (English)
1 reference
Wirth M
1 reference
Tyrrell C
1 reference
Wallace M
1 reference
Delaere KP
1 reference
Sánchez-Chapado M
1 reference
Ramon J
1 reference
Hetherington J
1 reference
Pina F
1 reference
Heynes CF
1 reference
Borchers TM
1 reference
Morris T
1 reference
Stone A
1 reference
1 August 2001
1 reference
1 reference
58
1 reference
2
1 reference
146-151
1 reference
Identifiers
1 reference
1 reference